Those two might be the biggest winners, but there are others that have gotten some help from retail investors, including Bed Bath and Beyond, BlackBerry, Koss, and Clover Health.

These “meme” stocks usually are based on one thing: They are weak companies. Nearly all of them are growing very slowly or losing money. They are mainly consumer companies that have faded from their highs.

However, one meme stock that has taken off is a very different type of company. The recent IPO ContextLogic (WISH) — which is also called Wish, the e-commerce system — has increased by 70% since the beginning of June on very high volume.

Wish is growing quickly and commands a big valuation. Is the WallStreetBets crowd getting into something good here? Let’s look at what the company has to offer.

This Tiny Square Could Solve The Supply Chain Crisis -- And Make You Rich

Democrats don't want conservative Patriots to know about this tiny square that could save American from Biden's failures....

Watch The Video

89,473

A Wish for big profits

Wish was started in 2010 and quickly grew. It reported a 34% revenue boost in 2020 to $2.5 billion. The company wants to distinguish itself by democratizing commerce with a personalized platform.

Wish’s business model offers a whimsical shopping experience with deeply discounted products, among other more normally priced items. And it copies social platforms like Pinduoduo by attempting to make shopping fun, giving sweepstakes and prizes for visiting and being loyal to the platform.

ContextLogic does not have the usual markers of a meme stock, but it does appear somewhat like the stocks on WallStreetBets.

Wish has gotten attention from some short-sellers (16% of its float was sold short at the end of May), and its not so good performance in the months after its IPO possibly got attention from the bargain-finding investors at WallStreetBets.

Compared to other growth stocks, Wish is very reasonably valued with a price-to-sales ratio near 3, about level with other e-commerce giants like Wayfair or even Amazon.

But the big question is, will they be able to make a profit? Its current model requires greater spending on giveaways for new customers, and it might be difficult to grow this expenses once customers expect those type of rewards.

Wish’s model seems unproven, and its claim that data science is crucial to its competitive advantage doesn’t seem accurate as the company goes head to head with Amazon, which is a master of data science.

For investors seeking out meme stocks, Wish is among the best. But given its problems with making a profit and differentiating itself, I would say this stock is best watched from the sidelines.

If you see $5 on the ground, you snatch it up, of course. Maybe you look around to see if someone may have dropped it before you claim it as your own.

But according to new Vanguard survey, getting free money is something that 401(k) investors are not doing. Specifically, the report says that 34% of 401(k) holders are not giving enough to get their full employer match.

Employer match refers to the money your employer puts in your 401(k) for free. To get the complete amount, you must give your own contribution up to a certain percentage. So, in terms of the money on the ground, you would throw down your own $5 bill first. Then you can get your $5 back plus another $5.

How the match works

Each company defines its own formula for matching, usually with two details:

The cap is your company’s maximum contribution. Normally a percentage of your salary. Vanguard says most caps are between 3% and 6% of salary.

This Tiny Square Could Solve The Supply Chain Crisis -- And Make You Rich

Democrats don't want conservative Patriots to know about this tiny square that could save American from Biden's failures....

Watch The Video

89,473

What it’s really worth

You might run the numbers on 6% of your salary and not be impressed. But when you review the value of your employee contributions over time, this shows you the impressive reality. For example, with only a 3% contribution in 30 years and a salary of $45,000, the ending value is $127,500.

Get your free money

Employer contributions can easily give you six figures of free money to your retirement over time. Taking advantage of this is as easy as picking up random $5 bills.

Ask your 401(k) manager to go over your company’s matching formula. Then increase your contribution to whatever is needed to claim your full match. And just like that, you will be in the group of 66% of 401(k) investors who are doing it the right way.

The real value of companies does not change so fast. But riding out the volatility is the price we have to pay to get long-term gains.

Owning a piece of high-quality companies with real advantages and tons of growth certainly helps. PayPal Holdings is one such company that you should consider to lower your concern during market turmoil.

Big success and competitive advantages

PayPal is among the largest online payment platforms out there. Since it came into the markets after its spinoff from eBay in 2015, the stock has been a big winner, increasing over 700%. Its user base was at 169 million accounts as of 2015; today, that has grown to an incredible 392 million. Through the first quarter this year, the firm has increased revenue at a growth of 18.8% over the previous five years, while net has grown even quicker, at a yearly rate of 31.3%.

When the company does go through rough patches, its strong advantages can ease investor worries. The company has two sources of such strength.

First, its double platform of consumers and merchants creates a powerful network lock in. Merchants will use PayPal if there are already many consumers who want to pay using the service, and vice versa. This means that with more customers, the ecosystem gets bigger. As the business gets momentum, it’s very hard for competitors to challenge this network effect.

This Tiny Square Could Solve The Supply Chain Crisis -- And Make You Rich

Democrats don't want conservative Patriots to know about this tiny square that could save American from Biden's failures....

Watch The Video

89,473

Second, the company’s success can also be connected to intangible assets, like its brand and innovation. Consumers and merchants understand that whenever they use PayPal, they are gaining top-notch security. Users therefore trust it with their credit card details and payment needs, and that is crucial.

Hold on and wait

Whenever the stock market looks to be losing and other people are panicking, it’s a good strategy to stick to owning top-rate businesses with a long-term goal. PayPal’s impressive history of success, continued growth, and other advantages make it the perfect choice for investors during any downturn.

That’s where the biotech company Mind Medicine steps in to give the solution. The company has several programs being developed, all of which seek to use the latest research and biotechnology to create psychiatric medicines that we have never seen before.

Will the stock make its investors millionaires, or is it yet another biotech that is having a moment right before it flares out?

The Details

Mind Medicine is creating several psychedelic products that go for expanding markets. Drugs that work on anxiety, depression, addiction, and ADHD account for around $30 billion in global spending every year.

If they succeed in their efforts with a psychedelic therapy, and that siphons off just a small portion of that amount annually, it will make their current investors rich.

This Tiny Square Could Solve The Supply Chain Crisis -- And Make You Rich

Democrats don't want conservative Patriots to know about this tiny square that could save American from Biden's failures....

Watch The Video

89,473

But because Mind Medicine has even more than one drug in the works, it has the ability to strike gold multiple times.

As of now, three of its therapies are in phase 2a of trials. Also, inside its target markets, the usual medications are habit-forming or have substantial side effects that can get worse over time. In comparison, Mind Medicine’s psychedelic therapy uses a growing amount of research that shows treatment using the drug can cause long-lasting relief with just one dose. And it is looking as though that relief does not seem to have the same risks of addiction or bad side effects.

That means Mind Medicine will benefit from an amazing competitive advantage against the current players if its research makes it through the trial process.

Finally, in certain cases, the market for existing therapies is pretty small compared to the total size of eligible patients. Just 36% of anxiety sufferers are estimated to look for treatment. So, there is plenty of room for the company’s innovative products to attract new demand on top of what is already there.